Dimethylphosphoryl-inhibited human cholinesterases: Inhibition, reactivation, and aging kinetics

Archives of Toxicology

Volumn 73, Issue 1, 1999, Pages 7-14

  Worek, F ^a   Diepold, C ^a   Eyer, P ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acetylcholinesterase; Human; Organophosphates; Oximes; Reactivation

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; MALATHION; OBIDOXIME; PARAOXON;

AGING; ARTICLE; CHOLINESTERASE INHIBITION; DOSE RESPONSE; ENZYME KINETICS; ENZYME REACTIVATION; HUMAN; INTOXICATION; PRIORITY JOURNAL; TOXICITY TESTING;

ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; CHOLINESTERASES; HUMANS; INSECTICIDES; KINETICS; OBIDOXIME CHLORIDE; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTHIOPHOSPHORUS COMPOUNDS; OXIMES; PARAOXON; PRALIDOXIME COMPOUNDS; PYRIDINES; PYRIDINIUM COMPOUNDS; TIME FACTORS;

EID: 0032892487     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050580     Document Type: Article

References (35)

1. Aldridge WN (1953) The inhibition of erythrocyte cholinesterase by tri-esters of phosphoric acid-3. The nature of the inhibitory process. Biochem J 54: 442-448
2. Aldridge WN, Davison AN (1953) The mechanism of inhibition of cholinesterases by organophosphorus compounds. Biochem J 55: 763-765
3. Aldridge WN, Reiner E (1972) Enzyme inhibitors as substrates -interactions of esterases with esters of organophosphorus and carbamic acids. North-Holland Publishing Company, Amsterdam London
4. Ballantyne B, Marrs TC (1992) Overview of the biological and clinical aspects of organophosphates and carbamates. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates. Butterworth and Heinemann, Oxford, pp 3-14
5. Bismuth C, Inns RH, Marrs TC (1992) Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In: Ballantyne B, Marrs TC (eds) Clinical and experimental toxicology of organophosphates and carbamates. Butterworth and Heinemann, Oxford, pp 555-577
6. de Jong LPA, Ceulen DI (1978) Anticholinesterase activity and rate of decomposition of some phosphylated oximes. Biochem Pharmacol 27: 857-863
7. de Jong LPA, Wolring GZ (1978) Effect of 1-(ar)-alkyl-hydroxy-iminomethyl-pyridinium salts on reactivation and aging of acetylcholinesterase inhibited by ethyldimethylphosphor-amidocyanidate (tabun). Biochem Pharmacol 27: 2229-2235
8. De Silva HJ, Wijewickrema R, Senanayake N (1992) Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet 339: 1136-1138
9. DuBois KP, Plzak GJ (1962) The acute toxicity and anticholinesterase action of O,O-dimethyl S-ethyl-2-sulfinylethyl phosphorothioate (Meta-Systox R) and related compounds. Toxicol Appl Pharmacol 4: 621-630
10. Ellman GL, Courtney KD, Anders V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95
11. Eyer P (1996) Optimal oxime dosage regimen, a pharmacokinetic approach. In: Szinicz L, Eyer P, Klimmek R (eds) Role of oximes in the treatment of anticholinesterase agent poisoning. Spektrum Akademischer Verlag, Heidelberg, pp 33-51
12. Eyer P, Mast U (1996) Pharmacokinetic aspects to improve oxime therapy in OP poisoning. Proceedings 2nd Chemical Biological Medical Treatment Symposium. Spiez, Switzerland, 7.-12.7.96 pp 88-93
13. Eyer P, Hagedorn I, Klimmek R, Lippstreu P, Löffler M, Oldiges H, Spöhrer U, Steidl I, Szinicz L, Worek F (1992) HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases. Arch Toxicol 66: 603-621
14. Finkelstein Y, Kushnir A, Raikhlin-Eisenkraft B, Taitelman U (1989) Antidotal therapy of severe acute organophosphate poisoning: a multihospital study. Neurotoxicol Teratol 11: 593-596
15. Gellhaus H, Hausmann E, Wellhöner HH (1989) Fast determination of demeton-S-methylsulfoxide (Metasystox R) in blood plasma. J Anal Toxicol 13: 330-332
16. Hassan RM, Pesce AJ, Sheng P, Hanenson IB (1981) Correlation of serum pseudocholinesterase and clinical course in two patients poisoned with organophosphate insecticides. Clin Toxicol 18: 401-406
17. Kleinschmidt S, Krämer T, Ziegenfuβ T (1994) Klinik, Analytik und Verlauf einer Intoxikation mit dem Alkylphosphat Demeton-S-Methylsulfoxid (Metasystox R). Anästhesiol Intensivmed Notfallmed Schmerzther 29: 249-251
18. Mason HJ, Waine E, Stevenson A, Wilson HK (1993) Aging and spontaneous reactivation of human plasma cholinesterase activity after inhibition by organophosphorus pesticides. Hum Exp Toxicol 12: 497-503
19. Mast U (1997) Reaktivierung der Erythrozyten-Acetylcholinesterase durch Oxime. Thesis, München
20. Namba T, Hiraki K (1958) PAM (pyridine-2-aldoxime methiodide) therapy for alkylphosphate poisoning. J Am Med Assoc 166: 1834-1839
21. Nenner M (1974) Phosphonylierte Aldoxime. Hemmwirkung auf Acetylcholinesterase und hydrolytischer Abbau. Biochem Pharmacol 23: 1255-1262
22. Schoene K, Strake EM (1971) Reaktivierung von Diäthylphosphoryl-Acetylcholinesterase-Affinität und Reaktivität einiger Pyridiniumoxime. Biochem Pharmacol 20: 1041-1051
23. Skrinjaric-Spoljar M, Simeon V, Reiner E (1973) Spontaneous reactivation and aging of dimethylphosphorylated acetylcholinesterase and cholinesterase. Biochim Biophys Acta 315: 363-369
24. Su CT, Wang PH, Lui RF, Shih JH, Ma C, Lin CH, Liu CY, Wu MT (1986) Kinetic studies and structure-activity relationships of bispyridinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Fundam Appl Toxicol 6: 506-514
25. Thiermann H, Mast U, Klimmek R, Eyer P, Hibler A, Pfab R, Felgenhauer N, Zilker T (1997) Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum Exp Toxicol 16: 473-480
26. Vandekar M, Heath DF (1957) The reactivation of cholinesterase after inhibition in vivo by some dimethylphosphate esters. Biochem J 67: 202-208
27. Wang EIC, Braid PE (1967) Oxime reactivation of diethyl-phosphoryl human serum cholinesterase. J Biol Chem 242: 2683-2687
28. Willems JL, De Bisshop HC, Verstraete AG, Declerck C, Christiaens Y, Vanscheeuwyck P, Buylaert WA, Vogelaers D, Colardyn F (1993) Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentrations of the oxime pralidoxime methylsulphate and of the organophosphate. Arch Toxicol 67: 79-84
29. Wilson IB, Ginsburg S (1955) A powerful reactivator of alkyl-phosphate-inhibited acetylcholinesterase. Biochem Biophys Acta 18: 168-170
30. Worek F, Kirchner T, Bäcker M, Szinicz L (1996) Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch Toxicol 70: 497-503
31. Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P (1997) Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 16: 466-472
32. Worek F, Widmann R, Knopff O, Szinicz L (1998a) Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 72: 237-243
33. Worek F, Eyer P, Szinicz L (1998b) Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Arch Toxicol 72: 580-587
34. Zech R, Engelhard H, Erdmann WD (1966) Reaktionen von Pyridinium Oximen mit dem Alkylphosphat Dimethoat und seinen Derivaten-Wirkung auf Cholinesterasen. Biochim Biophys Acta 128: 363-371
35. Zilker T, Hibler A (1996) Treatment of severe parathion poisoning: clinical aspects. In: Szinicz L, Eyer P, Klimmek R (eds) Role of oximes in the treatment of anticholinesterase agent poisoning. Spektrum Akademischer Verlag, Heidelberg, pp 9-17